Naph-Se-TMZ
Naph-Se-TMZ is a PROTAC-like HDAC1 degrader. Naph-Se-TMZ induces ROS-dependent reduction in HDAC1 protein expression and total HDAC activity, and decreases cell viability in a dose-dependent manner. Naph-Se-TMZ exhibits activity in both TMZ-sensitive and TMZ-resistant glioma cells, and its cytotoxicity is reversed by the ROS scavenger N-acetylcysteine (HY-B0215). Naph-Se-TMZ can be used in studies related to glioblastoma.
Naph-Se-TMZ consists of a target protein ligand (red segment): Temozolomide (HY-17364), a DNA intercalator (blue segment): Nitro-Naphthalimide-C2-acylamide (HY-169437), and a molecular linker (black segment). Meanwhile, the activity control for the target protein ligand is Temozolomide-amino hydrochloride (HY-169439), and the DNA intercalator+linker is NNISC-2 (HY-169438).
(Pink: HDAC and HDAC1 ligand (HY-17364); Blue: DNA Alkylator/Crosslinker ligand (HY-169437); Black: linker).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C21H16N10O6Se
- 分子量:583.38
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
PROTACs アイソフォーム固有の製品をすべて表示
More
生物活性
Naph-Se-TMZ consists of a target protein ligand (red segment): Temozolomide (HY-17364), a DNA intercalator (blue segment): Nitro-Naphthalimide-C2-acylamide (HY-169437), and a molecular linker (black segment). Meanwhile, the activity control for the target protein ligand is Temozolomide-amino hydrochloride (HY-169439), and the DNA intercalator+linker is NNISC-2 (HY-169438). (Pink: HDAC and HDAC1 ligand (HY-17364); Blue: DNA Alkylator/Crosslinker ligand (HY-169437); Black: linker).
|
HDAC1 |
Naph-Se-TMZ exhibits stronger binding affinity for human HDAC1 protein than TMZ or Vorinostat, and its interaction targets key residues in the catalytic channel of HDAC1[1].
Naph-Se-TMZ (96 h) reduces the HDAC1 protein level in TMZ-sensitive human glioma A172 cells, and this effect is reversed by the ROS scavenger NAC[1].
Naph-Se-TMZ (96 h) inhibits the total activity of class I/II HDACs in human TMZ-sensitive glioma A172 cells, and this effect is mediated in a ROS-dependent manner[1].
Naph-Se-TMZ (75-300 μM; 96 h) dose-dependently increases intracellular ROS levels in TMZ-sensitive human glioma A172 cells, and this effect can be partially reversed by the ROS scavenger NAC[1].
Naph-Se-TMZ (75-300 μM; 96 h) reduces the viability of human temozolomide (TMZ)-sensitive glioma A172 cells and human TMZ-resistant glioma LN18 cells in a dose-dependent manner, and this cytotoxic effect is mediated in a ROS-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human TMZ-sensitive glioma A172 cells, human TMZ-resistant glioma LN18 cells
-
Concentration:75 μM; 150 μM; 300 μM
-
Incubation Time:96 h
-
Result:Reduced cell viability by 20%, 40%, and 70% respectively at 75 μM, 150 μM, and 300 μM in A172 cells compared to control.
Reduced cell viability in a dose-dependent manner in LN18 cells compared to control.
Co-treatment with NAC significantly reversed the reduced cell viability induced by Naph-Se-TMZ alone in both cell lines.
化学情報
-
分子量 583.38
-
分子式 C21H16N10O6Se
-
SMILES
[Se]=C(NNC(C1=C2N(C(N(C)N=N2)=O)C=N1)=O)NCCN(C(C3=C4C(C=C(C=C54)[N+]([O-])=O)=CC=C3)=O)C5=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)